Leisure Capital Management - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Leisure Capital Management ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2018$283,000
+12.7%
4,645
-9.8%
0.23%
+7.5%
Q2 2018$251,000
-49.8%
5,147
+9.3%
0.21%
-51.4%
Q1 2018$500,000
-12.6%
4,709
-50.9%
0.44%
-7.4%
Q4 2017$572,000
+129.7%
9,582
-7.6%
0.48%
+117.9%
Q3 2017$249,000
+20.9%
10,367
-1.8%
0.22%
+19.1%
Q2 2017$206,000
-19.5%
10,553
-3.1%
0.18%
-19.4%
Q1 2017$256,000
+36.2%
10,890
-28.9%
0.23%
+34.3%
Q4 2016$188,000
-27.1%
15,322
+1.9%
0.17%
-30.2%
Q3 2016$258,000
+19.4%
15,043
-0.7%
0.24%
+14.2%
Q2 2016$216,000
+3.8%
15,146
+0.1%
0.21%
+2.9%
Q1 2016$208,000
-25.2%
15,136
-8.3%
0.21%
-18.6%
Q4 2015$278,000
+57.1%
16,514
+2.3%
0.25%
+31.8%
Q3 2015$177,000
-9.7%
16,139
+2.8%
0.19%
-0.5%
Q2 2015$196,000
+32.4%
15,699
+16.3%
0.19%
+33.1%
Q1 2015$148,000
-24.5%
13,500
+7.0%
0.14%
-23.3%
Q4 2014$196,00012,6160.19%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2017
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders